Drugs / Magnetite ZnO Composite Nanoparticles
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06271564 | Feb 2024 → Dec 2025 | oral cavity neoplasm | Ain Shams University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Magnetite ZnO Composite Nanoparticles | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06271564 ↗ |
| Route | Topical | “5% topical ZnO-Fe3O4 Magnetic Composite NPs gel applied 3 times per day for 6 weeks” NCT06271564 ↗ |